Genprex to progress Phase I/II trial of non-small cell lung cancer therapy
Progression-free survival is the primary endpoint of the Phase II portion of the trial.
Clinical Trials
Latest in
Clinical Trials
Gannex doses first participant in primary biliary cholangitis DDI study
ASC42 is also currently being analysed in a Phase II PBC trial enrolling 100 patients in China.
Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial
The chimeric endocrine receptor T-cell therapy of the company acts on the follicle stimulating hormone receptor.
Virios doses first subject in long Covid antiviral trial
IMC-2 merges valacyclovir and celecoxib together to hinder the herpes virus from activating and replicating.
Pipeline Moves: Lilly completes Phase II rheumatoid arthritis trial, next phase prospects rise
The Clinical Trials Arena team also investigate treatment candidates in colorectal cancer, retinal vein occlusion, and Raynaud’s disease.
By
Revealed: drug development companies best positioned to weather future industry disruption
Our analysis reveals that companies from USA are some of the best-prepared players in the drug development game.
By
Can AI remedy the growing pains of digital biomarker development?
AI implementation could be a useful tool to analyse generated data. Yet, regulatory approval hurdles are in sight.
By
ALX starts Phase II trial of colorectal cancer combo therapy
The investigator-sponsored, open-label, single-arm, multicentre trial is being managed by contract research organisation Criterium.